[go: up one dir, main page]

WO2009004900A1 - ユビキノン含有免疫アジュバント - Google Patents

ユビキノン含有免疫アジュバント Download PDF

Info

Publication number
WO2009004900A1
WO2009004900A1 PCT/JP2008/060642 JP2008060642W WO2009004900A1 WO 2009004900 A1 WO2009004900 A1 WO 2009004900A1 JP 2008060642 W JP2008060642 W JP 2008060642W WO 2009004900 A1 WO2009004900 A1 WO 2009004900A1
Authority
WO
WIPO (PCT)
Prior art keywords
immunoadjuvant
ubiquinone
vaccine composition
disclosed
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/060642
Other languages
English (en)
French (fr)
Inventor
Shuji Sato
Takeshi Goto
Naoya Ohmori
Kueichen Chiang
Yayoi Shimada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JOSAI UNIV CORP
Original Assignee
JOSAI UNIV CORP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JOSAI UNIV CORP filed Critical JOSAI UNIV CORP
Priority to JP2009521566A priority Critical patent/JPWO2009004900A1/ja
Publication of WO2009004900A1 publication Critical patent/WO2009004900A1/ja
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C50/00—Quinones
    • C07C50/26—Quinones containing groups having oxygen atoms singly bound to carbon atoms
    • C07C50/28—Quinones containing groups having oxygen atoms singly bound to carbon atoms with monocyclic quinoid structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

　本発明は、優れた抗体産生増強機能を有しかつ安全性の高い、免疫アジュバントおよびこれを含むワクチン組成物に関する。より詳しくは、本発明は、式（Ｉ）で表されるユビキノンを含んでなる免疫アジュバントおよびそのワクチン組成物に関する。 【化１】
PCT/JP2008/060642 2007-06-29 2008-06-11 ユビキノン含有免疫アジュバント Ceased WO2009004900A1 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009521566A JPWO2009004900A1 (ja) 2007-06-29 2008-06-11 ユビキノン含有免疫アジュバント

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92950907P 2007-06-29 2007-06-29
US60/929,509 2007-06-29

Publications (1)

Publication Number Publication Date
WO2009004900A1 true WO2009004900A1 (ja) 2009-01-08

Family

ID=40225954

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/060642 Ceased WO2009004900A1 (ja) 2007-06-29 2008-06-11 ユビキノン含有免疫アジュバント

Country Status (3)

Country Link
US (1) US20090252751A1 (ja)
JP (1) JPWO2009004900A1 (ja)
WO (1) WO2009004900A1 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023120535A1 (ja) 2021-12-20 2023-06-29 東興薬品工業株式会社 ポリアクリル酸系ポリマーを含有するワクチンアジュバント剤およびその使用

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5960596B2 (ja) * 2010-08-20 2016-08-02 学校法人 城西大学 免疫抑制活性を有するモノクローナル抗体またはその抗原結合断片

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000502087A (ja) * 1995-12-15 2000-02-22 ナショナル リサーチ カウンシル オブ カナダ アジュバンドおよび送達賦形剤としての、アーケオソーム類、補酵素ｑ▲下１０▼を含有するアーケオソーム類、および補酵素ｑ▲下１０▼を含有する他の種類のリポソーム類
WO2006025580A1 (ja) * 2004-09-03 2006-03-09 Amateraspharma Inc. 抗ヒストンｈ１モノクローナル抗体およびこれを産生するハイブリドーマ

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1450855B1 (en) * 2001-05-23 2009-08-26 Duotol Ab Suppression of allergic reactions by transdermal administration of allergens in conjunction with or conjugated to toxin subunits or fragments thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000502087A (ja) * 1995-12-15 2000-02-22 ナショナル リサーチ カウンシル オブ カナダ アジュバンドおよび送達賦形剤としての、アーケオソーム類、補酵素ｑ▲下１０▼を含有するアーケオソーム類、および補酵素ｑ▲下１０▼を含有する他の種類のリポソーム類
WO2006025580A1 (ja) * 2004-09-03 2006-03-09 Amateraspharma Inc. 抗ヒストンｈ１モノクローナル抗体およびこれを産生するハイブリドーマ

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
"Men'ekigaku Yogo Jiten, Kabushiki Kaisha Saishin Igakusha", 30 November 1984 (1984-11-30) *
AZUMA I. ET AL.: "The effect of ubiquinone-7 and its metabolites on the immune response. IV. Chemical structure-adjuvant activity relationship fo quinonyl derivatives on humoral immune response", INT. J. VITAM. NUTR. RES., vol. 48, no. 3, 1978, pages 255 - 261 *
MAKABI-PANZU B. ET AL.: "Coenzyme Q10 in vesicles composed of archaeal ether lipids or conventional lipids enahces the immuno-adjuvanticity to encapsulated protein", VACCINE, vol. 16, no. 16, 1998, pages 1504 - 1510, XP004129201 *
NAITO S.: "Keihi Men'eki Vaccine", CLINICAL IMMUNOLOGY & ALLERGOLOGY, vol. 47, no. 2, 25 February 2007 (2007-02-25), pages 226 - 231 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023120535A1 (ja) 2021-12-20 2023-06-29 東興薬品工業株式会社 ポリアクリル酸系ポリマーを含有するワクチンアジュバント剤およびその使用
KR20240122803A (ko) 2021-12-20 2024-08-13 도코 야쿠힌 고교 가부시키가이샤 폴리아크릴산 폴리머를 함유하는 백신 보조제 및 그의 사용

Also Published As

Publication number Publication date
US20090252751A1 (en) 2009-10-08
JPWO2009004900A1 (ja) 2010-08-26

Similar Documents

Publication Publication Date Title
WO2009156462A3 (en) Organic compounds
WO2008149345A3 (en) Tri-aryl compounds and compositions comprising the same
WO2008083248A3 (en) Cyclopamine analogs
WO2008148790A8 (en) Anti -inflammatory substituted cyclobutenedione compounds
WO2011153157A3 (en) Benzoquinolone inhibitors of vmat2
CA2798214C (en) Vaccine against beta-herpesvirus infection and use thereof
WO2008153154A1 (ja) 環状化合物、フォトレジスト基材及びフォトレジスト組成物
WO2011088027A8 (en) Compounds and methods
WO2010111436A3 (en) Antiviral compounds and uses thereof
WO2014121040A8 (en) Flap modulators
WO2011091376A3 (en) Immunogenic influenza composition
AU2007259257A8 (en) Antitumoral dihydropyran-2-one compounds
WO2008058118A3 (en) Preparation of montelukast and its salts
WO2012075117A3 (en) Small molecule-polymer conjugates and methods of making same
AU2010280497A8 (en) Anhydrate of tiotropium bromide
WO2014121055A3 (en) Flap modulators
WO2009074741A3 (fr) Nouveau procede de synthese du ranelate de strontium et de ses hydrates
WO2009146202A3 (en) Transketalized compositions, synthesis, and applications
WO2008073863A3 (en) Preparation and utility of substituted allylamines
WO2011088474A3 (en) Sulindac and sulindac derivatives and their uses related to infection
WO2009062659A3 (en) Polymorphs of enantiopure erdosteine
WO2009004900A1 (ja) ユビキノン含有免疫アジュバント
WO2011157388A8 (en) Process for the preparation of pteridine derivatives
WO2007136763A3 (en) Immunological composition
WO2013054204A3 (en) A process for making an intermediate of cabazitaxel

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08765421

Country of ref document: EP

Kind code of ref document: A1

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2009521566

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08765421

Country of ref document: EP

Kind code of ref document: A1